Share Name Share Symbol Market Type Share ISIN Share Description
Fevertree Drinks LSE:FEVR London Ordinary Share GB00BRJ9BJ26 ORD 0.25P
  Price Change % Change Share Price Shares Traded Last Trade
  -38.00p -1.05% 3,582.00p 287,406 16:35:24
Bid Price Offer Price High Price Low Price Open Price
3,584.00p 3,588.00p 3,657.00p 3,585.00p 3,622.00p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Beverages 170.17 56.43 39.48 90.7 4,132.4

Fevertree (FEVR) Latest News

More Fevertree News
Fevertree Takeover Rumours

Fevertree (FEVR) Share Charts

1 Year Fevertree Chart

1 Year Fevertree Chart

1 Month Fevertree Chart

1 Month Fevertree Chart

Intraday Fevertree Chart

Intraday Fevertree Chart

Fevertree (FEVR) Discussions and Chat

Fevertree Forums and Chat

Date Time Title Posts
18/7/201820:29FEVER TREE with chart3,025
06/7/201816:02Fevertree Drinks PLC (Fever-Tree)1,596
07/11/201423:50Is Fever Tree fairly Valued?-

Add a New Thread

Fevertree (FEVR) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2018-07-18 15:53:383,595.415,000179,770.40O
2018-07-18 15:53:243,615.003108.45O
2018-07-18 15:52:353,606.912007,213.82O
2018-07-18 15:52:103,610.9447217,043.63O
2018-07-18 15:35:243,582.0024,097863,154.54UT
View all Fevertree trades in real-time

Fevertree (FEVR) Top Chat Posts

Fevertree Daily Update: Fevertree Drinks is listed in the Beverages sector of the London Stock Exchange with ticker FEVR. The last closing price for Fevertree was 3,620p.
Fevertree Drinks has a 4 week average price of 3,288p and a 12 week average price of 2,639p.
The 1 year high share price is 3,673p while the 1 year low share price is currently 1,737p.
There are currently 115,366,102 shares in issue and the average daily traded volume is 0 shares. The market capitalisation of Fevertree Drinks is £4,132,413,773.64.
christh: It is heading upwards to £29 and higher. Take a hint fron this Director On 18 May 2018, Kevin Havelock,Non-Executive Director of the Company, bought, in aggregate, 9,000 ordinary shares of 0.25 pence each in the capital of the Company ("Ordinary Shares") at a volume weighted average price of 2,806.57 pence per Ordinary Share. 9,000 x £28.0657 =£252,591.3 That is very big money , meaning the directors are confident to move to higher places.
christh: On 18 May 2018, Kevin Havelock,Non-Executive Director of the Company, bought, in aggregate, 9,000 ordinary shares of 0.25 pence each in the capital of the Company ("Ordinary Shares") at a volume weighted average price of 2,806.57 pence per Ordinary Share.
christh: Sogoesit FFS you have no brains, you need an implant to get you going. How about an apology when I was saying that will hit £29 in the past? Mock and laugh, brainless idiot! Look where the share price is moving, can you see or you need Villa to back you up and show you the ropes?
bamboo2: I have an idea that there is kudos to be had from being 'the one' who calls the top in successful companies, such as FEVR, share price. Basically it becomes a publicity stunt. Hence the ra-ra from Norris. If it fails, it is quietly forgotten, if it succeeds then they will gain crowing rights. Cawkwell attempted it and seemingly failed in Jan '18. The reality for us PI's is that it can create some excellent buying opportunities. We know that there are numerous Breakaway gaps further down the chart. These are news or rns driven, and assuming the part of the story contained within these events or news holds true, then these are the places to draw support zones. I am unsure about the cause of the opening gap on 14 Feb at approx. 2328. Anyone remember? The next support zone down is 2270-2222 There is an unconfirmed H&S with a min tp approx. 2390
martywidget: finbarot 20 Mar '18 - 11:17 - 1502 of 1503(premium) Directors/chairman sale of shares about to be announced?? Fevertree Drinks PLC Proposed placing of shares in Fevertree Drinks PLC 22/03/2018 4:35pm ... Fever-Tree announces that it has been advised by Charles Rolls (the "Selling Shareholder"), one of the Company's founders and its Non-Executive Deputy Chairman, that he intends to sell approximately 1,500,000 ordinary shares in the Company (the "Placing Shares") via an accelerated bookbuild placing to institutional investors (the "Placing"). The Placing Shares represent approximately 1.3 per cent. of the issued share capital of Fever-Tree. Assuming that all of the Placing Shares are sold, the Selling Shareholder would continue to have an interest in 11,427,505 ordinary shares in the Company, representing approximately 9.9 per cent. of the Company's issued share capital...
villarich: I like the phrase 'they've tapped out the UK market.' I completely agree and the US story, along with the push on the dark spirits mixers is key to keeping the growth story going. And that's why I think we have possibly hit the top in terms of high growth which moves the share price at speed. We aren't going to see it double this year, far from it, but it should still grow. I see 20% uplift in the share price this year, barring no major issues.
sogoesit: Danny, as Villa says, it seemed a pretty odd question (for an accountant) but referring to gainer/loser lists share price (amount) movements are based on the underlying pence, or monetary, absolute change. Share price percentage gainers/losers reduce the share price movements to ranking them based on their movements as a percentage of their own share price. In general terms absolute price is not meaningful to rank gainers/losers... what matters is how much in proportional terms they have changed and also how much this change has been compared against an index or market. (Note Villa’s point about spreadbetting which is based on monetary absolutes... making high monetary numbered shares more interesting..)... ... if I’m right otherwise I better stick to the Great Wall! (But always beware, the market can make fools of us all and certainly has done in my case on numerous occasions ;-) )
christh: HA HA HA Calling the kettle black. I have not sell my shares at all, waiting for the takeover, £28 or £30. Results are known already. Waiting for the rumours of a possible or likely bidder in the scene. £26.85 was the highest price that Fevr price hit so it will be £26.85+10% to accept the offer
villarich: I've done some really rough analysis based on the limited financial information given in today's update to see where the share price might go over the next year or so. They are really rough figures with roundings but hopefully it all makes sense. I'll revisit when the full results are released. Last years reported Post-Tax Profit was £27.5m from revenues of £102m (roughly 27% of revenue was turned into PTP). Using that percentage on today's reported revenue figure, I'm getting £45.6m in profit which gives us EPS of 39.6p. I've rounded this to 40p for ease. I get a current multiple of 104 based on 24p EPS. If we applied 104 to 40p EPS we get a share price of £41. It would be wrong though to apply 104 to this EPS because the current multiple has that growth factored in. If we apply a multiple of 60 (this time last year the multiple was around 60) to 40p EPS we get £24. Right where we are now. If EPS does come in at 40p then EPS growth is 66%. Let's assume growth continues at a similar, albeit slightly lower pace of 50% this year. That gives us an EPS of 60p in 2018. Applying a multiple of 60 to that gives us a share price of £35.64. Again it's probably wrong to apply the same multiple again so a multiple of 50 gives us an share price of £29.70 (18% up from now). As I said there's loads of assumptions in here but I'd be interested to see the EPS in the full results and will revisit my thoughts. Overall, I won't be selling any time soon. Then again I wont be topping up either. It's a hold for me.
sogoesit: The article excerpt referred to in post 1013: "Fevertree (FEVR:AIM) £16.05 Current market status: LOVED Fevertree’s tonic water is increasingly the gin lover’s mixer of choice as it is considered a high quality product. The company has succeeded in getting its products stocked in a wide range of places, from supermarkets and restaurants to airlines and pubs. Fevertree has an asset-light, outsourced production model that means it is very cash generative and able to pay a progressive dividend. Its share price has risen 12-fold in value since joining the stock market in 2014. It has developed a reputation for providing conservative earnings guidance to analysts and subsequently over-delivering when financial numbers are reported. That has led to a continuous stream of earnings upgrades which have fuelled significant share price gains. FEVR - Comparison Line Chart (Rebased to first) WHAT ARE THE NEGATIVE POINTS FOR THE INVESTMENT CASE? 1. Could struggle to crack dark spirit market It is betting on a repeat of its tonic water success in the dark spirit mixers category. We think that’s a tall order. The market could punish the share price if the company cannot crack this market to same degree as it has done with light spirit mixers. Gin (a light spirit) and tonic is a refreshing drink where consumers clearly want high quality from both the spirit and the mixer, hence why Fevertree has done so well. However, dark spirits tend to be drunk neat, such as brandy, bourbon and whisky, so no need for fancy mixers. A mixer could cover up the true taste of whisky, for example, which defeats the object of enjoying that type of spirit. Water or ice would be acceptable mixers for whisky, but you don’t need a Fevertree-branded product. As for something like whisky and cola, surely that is the preferred drink of someone who is going after quantity over quality? Fevertree is now selling Madagascan Cola, which it claims to enhance ‘the complex flavours’ of the finest rums, whiskies and bourbons. Convincing shophisticated whisky drinkers to start adding cola to their favourite tipple will be a hard sell, in our opinion. 2. Is the business really worth £1.8bn? We note that Charles Rolls, one of the company’s founders and deputy chairman, last month sold £73.1m worth of shares. He cashed in £17.3m worth of shares when the company floated three years ago, plus earned £648,000 from Fevertree in pay and bonuses in 2016 alone – so hardly short of cash. Selling a large chunk now sends a negative signal to the market about the company’s future prospects. 3. Main Market plans We’ve heard talk that Fevertree is going to move to London’s Main Market. The company’s advisers say there are no plans at present, but we see this as a short-term risk to the share price if it does happen. The stock is a popular choice for investors wanting AIM shares that qualify for inheritance tax benefits. IHT portfolio managers would be forced to sell if Fevertree went to the Main Market as the shares would no longer qualify for the tax benefits."
Fevertree share price data is direct from the London Stock Exchange
add chat code
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20180719 00:03:43